iRadimed Corp (NAS:IRMD)
$ 56.2 3.46 (6.56%) Market Cap: 712.25 Mil Enterprise Value: 616.94 Mil PE Ratio: 38.49 PB Ratio: 8.53 GF Score: 96/100

Q2 2020 IRadimed Corp Earnings Call Transcript

Jul 30, 2020 / 03:00PM GMT
Release Date Price: $23.27 (+0.09%)
Operator

Welcome to IRadimed Corporation's Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, July 30, 2020, and contains time-sensitive information that is accurate only as of today.

Earlier, IRadimed released financial results for the second quarter 2020. A copy of this press release announcing the company's earnings is available under the heading News on their website at iradimed.com. A copy of the press release will also be furnished through the Securities and Exchange Commission on Form 8-K and can be found at sec.gov. This call is being broadcast live over the Internet on the company's website at iradimed.com, and a replay of the call will be available on the website for the next 90 days.

The agenda for today's call will be as follows: Roger Susi, President and Chief Executive Officer of IRadimed, will present opening comments; then Chris Scott, IRadimed's Chief Financial Officer, will summarize the company's financial results before opening the call up to questions.

Some of the information to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot